Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:36 AM
Ignite Modification Date:
2025-12-25 @ 4:36 AM
NCT ID:
NCT01717118
Eligibility Criteria:
Inclusion Criteria:
* • Women 18 to 24 years of age who agree to participate by signing an informed consent form prior to recruitment.
* Girls 9 and 10 years of age whose father/mother/guardian signs the informed consent form to participate in the study.
Exclusion Criteria:
* • Prior administration of an anti-HPV vaccine
* Pregnant women or women planning to get pregnant in the next 8 months.
* Auto-immune diseases
* Women with a history of Guillain Barré syndrome.
* Prior administration of immunoglobulins and/or any blood product in the past 6 months before the study's first vaccine dose.
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
9 Years
Maximum Age:
24 Years
Study:
NCT01717118
Study Brief:
Protocol Section:
NCT01717118